首页    期刊浏览 2024年12月05日 星期四
登录注册

文章基本信息

  • 标题:Le conseguenze sulla spesa farmaceutica pubblica di un nuovo inibitore di pompa protonica: esomeprazolo
  • 本地全文:下载
  • 作者:C. Lucioni ; S. Mazzi ; C. Negrini
  • 期刊名称:Farmeconomia. Health economics and therapeutic pathways
  • 印刷版ISSN:2240-256X
  • 出版年度:2002
  • 卷号:3
  • 期号:1
  • 页码:5-14
  • DOI:10.7175/fe.v3i1.739
  • 语种:English
  • 出版社:SEEd
  • 摘要:Aim of the present study is to check the economic advantage of esomeprazole, a new proton pump inhibitor that suppresses gastric acid secretion. The efficacy and tolerability of esomeprazole have been already demonstrated, now the pharmacoeconomic studies must investigate the possible savings for the SSN in case of esomeprazole immission on the Italian market. In this paper the authors present two pharmacoeconomic evaluations, the first based on cost/efficacy analysis, the second based on cost minimization analysis. For both analyses, the term of comparison is omeprazole, “gold standard” in the treatment of acid reflux-related pathologies. The effect in terms of volumes (DDD) and costs of the introduction of esomeprazole in the italian market has also been simulated.
  • 关键词:Pharmacoeconomics; Health economics
国家哲学社会科学文献中心版权所有